Pharma

Your Article Summary

See Latest Articles

Mylan Receives Tentative FDA Approval for Generic Version of Singulair
Mylan, 06/01/09

Mylan Inc. announced that it has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Montelukast Sodium Tablets, 10 mg. Montelukast Sodium Tablets are the generic version of Merck and Co.'s Singulair, which had total U.S. sales of approximately $2.6 billion for the 12 months ending March for the same strength, according to IMS Health. This product is indicated for asthma and allergy treatment.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals